These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
3. Efficacy and safety of aripiprazole or bupropion augmentation and switching in patients with treatment-resistant depression or major depressive disorder: A systematic review and meta-analysis of randomized controlled trials. Ji M; Feng J; Liu G PLoS One; 2024; 19(4):e0299020. PubMed ID: 38669232 [TBL] [Abstract][Full Text] [Related]
4. Comparison of the Efficacy and Safety of Aripiprazole Versus Bupropion Augmentation in Patients With Major Depressive Disorder Unresponsive to Selective Serotonin Reuptake Inhibitors: A Randomized, Prospective, Open-Label Study. Cheon EJ; Lee KH; Park YW; Lee JH; Koo BH; Lee SJ; Sung HM J Clin Psychopharmacol; 2017 Apr; 37(2):193-199. PubMed ID: 28129308 [TBL] [Abstract][Full Text] [Related]
5. Predictors and Moderators of Remission With Aripiprazole Augmentation in Treatment-Resistant Late-Life Depression: An Analysis of the IRL-GRey Randomized Clinical Trial. Kaneriya SH; Robbins-Welty GA; Smagula SF; Karp JF; Butters MA; Lenze EJ; Mulsant BH; Blumberger D; Anderson SJ; Dew MA; Lotrich F; Aizenstein HJ; Diniz BS; Reynolds CF JAMA Psychiatry; 2016 Apr; 73(4):329-36. PubMed ID: 26963689 [TBL] [Abstract][Full Text] [Related]
6. Efficacy, safety, and tolerability of augmentation pharmacotherapy with aripiprazole for treatment-resistant depression in late life: a randomised, double-blind, placebo-controlled trial. Lenze EJ; Mulsant BH; Blumberger DM; Karp JF; Newcomer JW; Anderson SJ; Dew MA; Butters MA; Stack JA; Begley AE; Reynolds CF Lancet; 2015 Dec; 386(10011):2404-12. PubMed ID: 26423182 [TBL] [Abstract][Full Text] [Related]
7. Lithium or an atypical antipsychotic drug in the management of treatment-resistant depression: a systematic review and economic evaluation. Edwards SJ; Hamilton V; Nherera L; Trevor N Health Technol Assess; 2013 Nov; 17(54):1-190. PubMed ID: 24284258 [TBL] [Abstract][Full Text] [Related]
8. Effect of Antidepressant Switching vs Augmentation on Remission Among Patients With Major Depressive Disorder Unresponsive to Antidepressant Treatment: The VAST-D Randomized Clinical Trial. Mohamed S; Johnson GR; Chen P; Hicks PB; Davis LL; Yoon J; Gleason TC; Vertrees JE; Weingart K; Tal I; Scrymgeour A; Lawrence DD; Planeta B; Thase ME; Huang GD; Zisook S; ; Rao SD; Pilkinton PD; Wilcox JA; Iranmanesh A; Sapra M; Jurjus G; Michalets JP; Aslam M; Beresford T; Anderson KD; Fernando R; Ramaswamy S; Kasckow J; Westermeyer J; Yoon G; D'Souza DC; Larson G; Anderson WG; Klatt M; Fareed A; Thompson SI; Carrera CJ; Williams SS; Juergens TM; Albers LJ; Nasdahl CS; Villarreal G; Winston JL; Nogues CA; Connolly KR; Tapp A; Jones KA; Khatkhate G; Marri S; Suppes T; LaMotte J; Hurley R; Mayeda AR; Niculescu AB; Fischer BA; Loreck DJ; Rosenlicht N; Lieske S; Finkel MS; Little JT JAMA; 2017 Jul; 318(2):132-145. PubMed ID: 28697253 [TBL] [Abstract][Full Text] [Related]
13. General Predictors and Moderators of Depression Remission: A VAST-D Report. Zisook S; Johnson GR; Tal I; Hicks P; Chen P; Davis L; Thase M; Zhao Y; Vertrees J; Mohamed S Am J Psychiatry; 2019 May; 176(5):348-357. PubMed ID: 30947531 [TBL] [Abstract][Full Text] [Related]
14. Comparing Cost-Effectiveness of Aripiprazole Augmentation With Other "Next-Step" Depression Treatment Strategies: A Randomized Clinical Trial. Yoon J; Zisook S; Park A; Johnson GR; Scrymgeour A; Mohamed S J Clin Psychiatry; 2018 Dec; 80(1):. PubMed ID: 30695291 [TBL] [Abstract][Full Text] [Related]
15. Antidepressants for people with epilepsy and depression. Maguire MJ; Marson AG; Nevitt SJ Cochrane Database Syst Rev; 2021 Apr; 4(4):CD010682. PubMed ID: 33860531 [TBL] [Abstract][Full Text] [Related]
16. Psychiatric and physical outcomes of long-term use of lithium in older adults with bipolar disorder and major depressive disorder: A cross-sectional multicenter study. Morlet E; Costemale-Lacoste JF; Poulet E; McMahon K; Hoertel N; Limosin F; J Affect Disord; 2019 Dec; 259():210-217. PubMed ID: 31446382 [TBL] [Abstract][Full Text] [Related]
17. If at first you don't succeed: a review of the evidence for antidepressant augmentation, combination and switching strategies. Connolly KR; Thase ME Drugs; 2011 Jan; 71(1):43-64. PubMed ID: 21175239 [TBL] [Abstract][Full Text] [Related]
18. Augmentation With Aripiprazole or Bupropion, or a Switch to Nortriptyline, Effective for Treatment-Resistant Depression in Older Adults. Ebell MH Am Fam Physician; 2023 Sep; 108(3):Online. PubMed ID: 37725473 [No Abstract] [Full Text] [Related]
19. Clinicians' Views on Treatment-Resistant Depression: 2016 Survey Reports. Arandjelovic K; Eyre HA; Lavretsky H Am J Geriatr Psychiatry; 2016 Oct; 24(10):913-7. PubMed ID: 27591914 [TBL] [Abstract][Full Text] [Related]
20. Combining mirtazapine with SSRIs or SNRIs for treatment-resistant depression: the MIR RCT. Kessler D; Burns A; Tallon D; Lewis G; MacNeill S; Round J; Hollingworth W; Chew-Graham C; Anderson I; Campbell J; Dickens C; Macleod U; Gilbody S; Davies S; Peters TJ; Wiles N Health Technol Assess; 2018 Nov; 22(63):1-136. PubMed ID: 30468145 [TBL] [Abstract][Full Text] [Related] [Next] [New Search]